- Home
- Publications
- Publication Search
- Publication Details
Title
Masitinib for gastrointestinal stromal tumors
Authors
Keywords
-
Journal
Expert Opinion on Orphan Drugs
Volume 4, Issue 6, Pages 671-676
Publisher
Informa UK Limited
Online
2016-05-05
DOI
10.1080/21678707.2016.1180973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
- (2015) G. Deplanque et al. ANNALS OF ONCOLOGY
- Masitinib for the treatment of mild to moderate Alzheimer’s disease
- (2015) Jaume Folch et al. Expert Review of Neurotherapeutics
- GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer
- (2015) Angela Cioffi et al. JOURNAL OF CLINICAL ONCOLOGY
- Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
- (2015) Jean-Yves Blay et al. LANCET ONCOLOGY
- Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient
- (2015) Maria Salvado WORLD JOURNAL OF GASTROENTEROLOGY
- Masitinib for the treatment of mild to moderate Alzheimer’s disease
- (2015) Jaume Folch et al. Expert Review of Neurotherapeutics
- Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial
- (2014) A. Adenis et al. ANNALS OF ONCOLOGY
- Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
- (2014) Joyce O'Shaughnessy et al. JOURNAL OF CLINICAL ONCOLOGY
- A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
- (2013) K. N. Ganjoo et al. ANNALS OF ONCOLOGY
- Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment—Past, Present, and Future Aspects
- (2013) Paulus S. Rommer et al. Current Treatment Options in Neurology
- Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy
- (2013) Sabrina Angelini et al. PHARMACOGENOMICS
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
- (2012) Patrick Vermersch et al. BMC Neurology
- Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis
- (2012) M. Montemurro et al. EUROPEAN JOURNAL OF CANCER
- Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor
- (2012) Sophie Georgin-Lavialle et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The Tyrosine Kinase Inhibitor Masitinib Blunts Airway Inflammation and Improves Associated Lung Mechanics in a Feline Model of Chronic Allergic Asthma
- (2012) Tekla M. Lee-Fowler et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
- (2011) Hedy L Kindler et al. LANCET ONCOLOGY
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study
- (2010) Carle Paul et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
- (2010) Emmanuel Mitry et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)
- (2010) Axel Le Cesne et al. EUROPEAN JOURNAL OF CANCER
- Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Meta-Analysis of 1,640 Patients
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
- (2010) Armin Wolf et al. LEUKEMIA RESEARCH
- A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
- (2010) Zahra Raisi Estabragh et al. LEUKEMIA RESEARCH
- Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics
- (2009) M. Humbert et al. ALLERGY
- Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers
- (2009) J.C. Soria et al. EUROPEAN JOURNAL OF CANCER
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
- (2009) Jacques Tebib et al. ARTHRITIS RESEARCH & THERAPY
- More about masitinib
- (2009) Ulrich A Walker ARTHRITIS RESEARCH & THERAPY
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
- (2008) Jean-Philippe Spano et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now